Company Filing History:
Years Active: 2013
Title: Ajay Shankar Singh: Innovator in Cancer Treatment
Introduction
Ajay Shankar Singh is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has led to the development of a unique patent that addresses critical medical needs.
Latest Patents
Ajay Shankar Singh holds a patent for the invention titled "Sorafenib dimethyl sulphoxide solvate." This invention provides a dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpyridine-2-carboxamide. The patent outlines the process for its preparation, pharmaceutical composition comprising it, and its use for the treatment of cancer. Additionally, it introduces a novel HPLC method for the identification, quantification, and isolation of related substances of sorafenib.
Career Highlights
Ajay Shankar Singh is currently associated with Ranbaxy Laboratories, Inc., where he continues to work on innovative pharmaceutical solutions. His expertise and dedication to research have positioned him as a valuable asset in the field of drug development.
Collaborations
He has collaborated with notable coworkers such as Jagdev Singh Jaryal and Swargam Sathyanarayana, contributing to a dynamic and innovative work environment.
Conclusion
Ajay Shankar Singh's contributions to cancer treatment through his patent and work at Ranbaxy Laboratories, Inc. highlight his commitment to advancing medical science. His innovative spirit continues to inspire others in the field of pharmaceuticals.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.